Coronavirus: Merck files for U.S. approval of its Covid pill
Sylvie Claire / October 11, 2021
The American laboratory Merck announced on Monday that it had filed an application for authorization with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
The application is for Merck's drug molnupiravir for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and/or hospitalization, the company said in a statement.
Related Posts
European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
Steph Deschamps / January 28, 2022
The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-C...
Read More
Coronavirus: Biden administration withdraws mandatory vaccination in large companies
Steph Deschamps / January 26, 2022
President Joe Biden's administration on Tuesday formally withdrew the vaccinatio...
Read More
Public humiliation in China: accused of violating anti-Covid measures, they are forced to march in handcuffs in the streets.
Sylvie Claire / December 30, 2021
Four people accused of violating anti-Covid rules were forced to parade in the sou...
Read More